Robert Nowinski, PhD, to VP-new technology. Science & Technology Group. He continues as a corporate VP and president of subsidiary Genetic Systems. Nowinski was a founder of Genetic Systems, acquired by Bristol in 1986; Marvin Gorman, PhD, to exec VP of biotech research subsidiary Oncogen; Charles Heimbold, president of B-M's Health Care (non-pharmaceutical) Group, will assume corporate responsibility for planning and development, succeeding John Melton, who has resigned.
You may also be interested in...
Internal FDA emails obtained by the Environmental Working Group through a FOIA request indicate that the agency was moving toward rulemaking in 2016 to restrict or prohibit use of formaldehyde in heated hair-straightening cosmetics, but seemingly abandoned the initiative. That has Congress, NGOs and other stakeholders asking questions and renewing calls for cosmetics regulatory reform.
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.